| Product Code: ETC7661975 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Small Molecule Drug Discovery Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Small Molecule Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Small Molecule Drug Discovery Market - Industry Life Cycle |
3.4 Israel Small Molecule Drug Discovery Market - Porter's Five Forces |
3.5 Israel Small Molecule Drug Discovery Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.6 Israel Small Molecule Drug Discovery Market Revenues & Volume Share, By Process/Phase, 2021 & 2031F |
4 Israel Small Molecule Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in Israel's pharmaceutical sector |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Technological advancements in drug discovery processes, such as high-throughput screening and computational modeling |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Israel |
4.3.2 Limited availability of skilled workforce in the field of drug discovery |
4.3.3 High costs associated with small molecule drug development and testing |
5 Israel Small Molecule Drug Discovery Market Trends |
6 Israel Small Molecule Drug Discovery Market, By Types |
6.1 Israel Small Molecule Drug Discovery Market, By Therapeutic Area |
6.1.1 Overview and Analysis |
6.1.2 Israel Small Molecule Drug Discovery Market Revenues & Volume, By Therapeutic Area, 2021- 2031F |
6.1.3 Israel Small Molecule Drug Discovery Market Revenues & Volume, By Oncology, 2021- 2031F |
6.1.4 Israel Small Molecule Drug Discovery Market Revenues & Volume, By Central Nervous System, 2021- 2031F |
6.1.5 Israel Small Molecule Drug Discovery Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.1.6 Israel Small Molecule Drug Discovery Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.1.7 Israel Small Molecule Drug Discovery Market Revenues & Volume, By Metabolic Disorders, 2021- 2031F |
6.1.8 Israel Small Molecule Drug Discovery Market Revenues & Volume, By Gastrointestinal, 2021- 2031F |
6.2 Israel Small Molecule Drug Discovery Market, By Process/Phase |
6.2.1 Overview and Analysis |
6.2.2 Israel Small Molecule Drug Discovery Market Revenues & Volume, By Target ID/Validation, 2021- 2031F |
6.2.3 Israel Small Molecule Drug Discovery Market Revenues & Volume, By Hit Generation and Selection, 2021- 2031F |
6.2.4 Israel Small Molecule Drug Discovery Market Revenues & Volume, By Lead Identification, 2021- 2031F |
6.2.5 Israel Small Molecule Drug Discovery Market Revenues & Volume, By Lead Optimization, 2021- 2031F |
7 Israel Small Molecule Drug Discovery Market Import-Export Trade Statistics |
7.1 Israel Small Molecule Drug Discovery Market Export to Major Countries |
7.2 Israel Small Molecule Drug Discovery Market Imports from Major Countries |
8 Israel Small Molecule Drug Discovery Market Key Performance Indicators |
8.1 Number of patents filed for small molecule drug discoveries in Israel |
8.2 Percentage of research funding allocated to small molecule drug discovery projects |
8.3 Rate of adoption of innovative drug discovery technologies in Israel's pharmaceutical industry |
9 Israel Small Molecule Drug Discovery Market - Opportunity Assessment |
9.1 Israel Small Molecule Drug Discovery Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.2 Israel Small Molecule Drug Discovery Market Opportunity Assessment, By Process/Phase, 2021 & 2031F |
10 Israel Small Molecule Drug Discovery Market - Competitive Landscape |
10.1 Israel Small Molecule Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 Israel Small Molecule Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here